• Partners
  • Patents
  • Blog
  • White Papers
  • xMAP® Insights Magazine
    • xMAP® Insights 2022 Issue
    • xMAP® Insights 2021 Issue 2
    • xMAP® Insights 2021 Issue 1
    • xMAP® Insights 2020 Issue
    • xMAP® Insights 2019 Issue
    • xMAP® Insights 2018 Issue
    • xMAP® Insights 2017 Issue 2
    • xMAP® Insights 2017 Issue 1
    • xMAP® Insights 2016 Issue
  • Cancer
  • Video Pages
    • xMAP® Technology Videos
    • VERIGENE® System Videos
    • Luminex® 100/200 Videos
  • Terms & Policies
    • Reagent Shipping Policy
    • Terms & Conditions of Sale United States
    • Terms & Conditions of Sale International
  • Menu Menu
  • Please Note: Training requests should be submitted at least 1 to 2 weeks prior to the desired training date. Trainees should have admin privileges on their computer before attending sessions.

    Requirement: New hire set up must be complete before proceeding to a training request. All internal trainees must have an active employee record in the Luminex Salesforce instance. For additional background on this process contact the Luminex HR department.

  • Hint: Hold down CTRL (Windows) or CMD (OSX) to select multiple items
Scroll to top

Follow us

Group

  • Company
  • Sustainability
  • Investors
  • Careers
  • Newsroom

Our Solutions

  • Immunodiagnostics
  • Molecular Diagnostics
  • Luminex LTG

Useful Links

  • Contact us
  • Diasorin worldwide
  • Immuno products Catalog
  • My Luminex

Legal Information

  • Legal notice
  • Privacy policy
  • Modern slavery statement
  • Accessibility

Document Repository

Diasorin Immuno and Molecular product documentation

Dialog

Licensed Technologies and Luminex products

Product documentation

DiaSorin S.p.A. - Share Capital €55.948.257 R.E.A. 180729 - Fiscal Code and Subscription to Vercelli Companies Register no 13144290155